Evidence map›Paper›PMID 38262608›Full record

ArticleProceedings. Biological sciences2024

My host's enemy is my enemy: plasmids carrying CRISPR-Cas as a defence against phages.

Berit Siedentop, Dario Rüegg, Sebastian Bonhoeffer, Hélène Chabas

Open access · hybridAbstract read
In one paragraph

Article in Proceedings. Biological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Berit SiedentopInstitute for Integrative Biology, ETH Zürich, Zürich, Switzerland.ORCID 0000-0003-0802-7681
Dario RüeggInstitute for Integrative Biology, ETH Zürich, Zürich, Switzerland.
Sebastian BonhoefferInstitute for Integrative Biology, ETH Zürich, Zürich, Switzerland.ORCID 0000-0001-8052-3925
Hélène ChabasInstitute for Integrative Biology, ETH Zürich, Zürich, Switzerland.ORCID 0000-0001-9792-3589
ETH Zurich · CH

Funding

ETH Zurich Postdoctoral Fellowship
6 · The paper itself

Abstract

Bacteria are infected by mobile genetic elements like plasmids and virulent phages, and those infections significantly impact bacterial ecology and evolution. Recent discoveries reveal that some plasmids carry anti-phage immune systems like CRISPR-Cas, suggesting that plasmids may participate in the coevolutionary arms race between virulent phages and bacteria. Intuitively, this seems reasonable as virulent phages kill the plasmid's obligate host. However, the efficiency of CRISPR-Cas systems carried by plasmids can be expected to be lower than those carried by the chromosome due to continuous segregation loss, creating susceptible cells for phage amplification. To evaluate the anti-phage protection efficiency of CRISPR-Cas on plasmids, we develop a stochastic model describing the dynamics of a virulent phage infection against which a conjugative plasmid defends using CRISPR-Cas. We show that CRISPR-Cas on plasmids provides robust protection, except in limited parameter sets. In these cases, high segregation loss favours phage outbreaks by generating a population of defenceless cells on which the phage can evolve and escape CRISPR-Cas immunity. We show that the phage's ability to exploit segregation loss depends strongly on the evolvability of both CRISPR-Cas and the phage itself.

Indexed as

BacteriophagesCRISPR-Cas SystemsDisease OutbreaksEcologyPlasmidscoevolutionCRISPR-Casevolutionary emergencemobile genetic elementsphagesplasmids

Identifiers

PMID38262608
PMCPMC10805597
OpenAlexW4391151818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.